Sheffield Institute for
Translational Neuroscience

Dr Jon Wood PhD

Senior University Teacher

Research Interests

Current Projects


Dr Wood has authored over 30 peer-reviewed publications of original research.

Key Publications

Lorente Pons A, Higginbottom A, Cooper‐Knock J, Alrafiah A, Alofi E, Kirby J, Shaw PJ, Wood JD & Highley JR (2020) Oligodendrocyte pathology exceeds axonal pathology in white matter in human amyotrophic lateral sclerosis. The Journal of Pathology, 251(3):262-271. 

Eachus H, Bright C, Cunliffe VT, Placzek M, Wood JD & Watt PJ (2017) Disrupted-in-Schizophrenia-1 is essential for normal hypothalamic-pituitary-interrenal (HPI) axis function. Human Molecular Genetics, 26(11), 1992-2005.

Highley JR, Pons AL, Cooper‐Knock J, Wharton SB, Ince PG, Shaw PJ, Wood J & Kirby J (2016) Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate‐length CAG repeat expansions in Ataxin‐2 does not have 1C2‐positive polyglutamine inclusions. Neuropathology and Applied Neurobiology, 42(4), 377-389.

Seytanoglu A, Alsomali NI, Valori CF, McGown A, Kim HR, Ning K, Ramesh T, Sharrack B, Wood JD & Azzouz M (2016) Deficiency in the mRNA export mediator Gle1 impairs Schwann cell development in the zebrafish embryo. Neuroscience, 322, 287-297.

Wood JD, cunliffe VT, Roy S & Boyd PB (2015) Sonic hedgehog functions upstream of disrupted-in-schizophrenia 1 (disc1): implications for mental illness. Biology Open, 4(10):1336-43. 

Fullstone, G., Wood, J., Holcombe, M. & Battaglia, G. (2015). Modelling the transport of nanoparticles under blood flow using an agent-based approach. Scientific Reports 5:10649.

Butler, R., Wood, J.D., Landers, J.A. & Cunliffe, V.T. (2010). Genetic and chemical modulation of Spastin-dependent axon outgrowth in zebrafish embryos indicates a role for impaired microtubule dynamics in Hereditary Spastic Paraplegia. Disease Models and Mechanisms Abstract

Wood, J.D., Bonath, F., Kumar, S., Ross, C.A. & Cunliffe, V.T. (2009). Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain. Human Molecular Genetics 18, 391-404. Abstract

Sato, T., Miura, M., Yamada, M., Yoshida, T., Wood, J.D., Yazawa, I., Masuda, M., Suzuki, T., Shin, R.-M., Yau, H.-J., Liu, F.-C., Shimohata, T., Igarashi, S., Onodera, O., Ross, C.A., Katsuki, M., Takahashi, H., Kano, M., Aosaki, T. & Tsuji, S. (2009). Severe neurological phenotypes of Q129 DRPLA transgenic mice serendipitously created by en masse expansion of CAG repeats in Q76 DRPLA mice. Human Molecular Genetics 18, 723-736. Abstract

Kasher, P.R., De Vos, K.J., Wharton, S.B., Manser, C., Bennett, E.J., Bingley, M., Wood, J.D., Milner, R., McDermott, C.J., Miller, C.C.J., Shaw, P.J. & Grierson, A.J. (2009). Direct evidence for axonal transport defects in a novel mouse model of mutant spastin-induced hereditary spastic paraplegia (HSP) and human HSP patients. Journal of Neurochemistry 110, 34-44 Abstract

Wood, J.D., Landers, J.A., Bingley, M., McDermott, C.J., Thomas-McArthur, V.T., Gleadall, L.J., Shaw, P.J. & Cunliffe, V.T. (2006). The microtubule-severing protein spastin is required for motor axon outgrowth in the zebrafish embryo. Human Molecular Genetics 15, 2763-2771. Abstract.

Professional Activities


Dr Wood obtained a PhD in Biochemistry from the University of Bristol in 1993. He undertook postdoctoral training at the University of Wales College of Medicine from 1993–1996, working on the neurobiology of Huntington’s disease with Dr Lesley Jones and Professor Peter Harper. In 1996 he was awarded an MRC International Travelling Fellowship, which was held in the laboratory of Professor Christopher Ross at the Johns Hopkins Medical Institutions in Baltimore, USA. He undertook further postdoctoral work on the molecular pathogenesis of dentatorubral-pallidoluysian atrophy (DRPLA) in the Ross laboratory from 1997-2001 and discovered that nuclear accumulation of mutant Atrophin-1 is an early step in the pathobiology of DRPLA (Schilling et al., 1999; Yamada et al., 2001), and that Atrophin-1 functions as a transcriptional repressor (Wood et al., 2000). He was appointed to a non-clinical lectureship in Neuroscience at the University of Sheffield in 2001.

Teaching Interests

Dr Wood is course lead for the MSc Clinical Neurology and MSc Neuroscience and Neurodegeneration

He also teaches on the MBChB programme, MSc Translational Neuroscience, MSc Translational Neuropathology, MSc Genomic Medicine and MSc Molecular Medicine.

He is a Senior Fellow of the Higher Education Academy and a Senate Fellow for his work in development of a video resource for neuroanatomy teaching.

Contact Details

University of Sheffield
Department of Neuroscience
Sheffield Institute for Translational Neuroscience
Room B28
385a Glossop Road
S10 2HQ

T: +44 (0)114 22 22243